combination therapy with cisplatin ( cddp ) and uft , a drug prepared with 1- ( tetrahydro-2-furanyl ) -5-fluorouracil and uracil at a mixing molar ratio of 1:4 , was examined in nude mice bearing transplantable human nasopharyngeal hybrid cell ( a2l/ah ) .
C0016360
5-fluorouracil
C0041917
uracil